Greenphire's ConneX travel service helps a global rare disease biotech drive retention by easing logistical burdens for their study participants
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Metastatic Breast Cancer Alliance bolsters patient engagement and data insights with Greenphire’s patient-powered research registry
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Clinical trial sponsor drives global site adoption and process optimization
ClinCard + ConneX:A win-win for all
Originally published on the Greenphire website prior to the...
Survey says: Global patient perceptions and engagement preferences in clinical research 2022
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
2022 market trends survey results
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Amplifying patient voices in rare disease trials
Understanding patient and caregiver experiences and how effective patient support strategies reduce...
Curis reduces risks of complex oncology trial using Suvoda IRT
How an intuitive, flexible system paired with a consistent, cross-functional team of IRT experts...
Bellerophon Therapeutics manages a successful phase 2/3 direct-to-patient trial using IRT
How Bellerophon Therapeutics is using IRT to successfully handle the multiple layers of complexity...
Grünenthal automates the IRT receipt process for temperature monitored shipments
How Grünenthal leveraged Suvoda IRT to turn a long and costly manual process into a same-day,...
Cara Therapeutics solves complexity with IRT and EDC integration
How a Successful IRT and EDC Integration Saves Time
Pharmaceutical companies face strict timelines...